The drug development sector in the United States is experiencing a substantial surge in requirement for Tirzepatide APIs. This effective medication, used to treat glucose intolerance, has attracted extensive attention from both patients and healthcare professionals. As a result, numerous companies have emerged as producers of Tirzepatide APIs in th